Fund Holdings — BVF INC/IL

Total Portfolio Value:
$3.57B
Total Bought:
$459.86M
Total Sold:
$221.78M
Net Transaction:
+$238.08M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)21,751,28421,751,2840$1.09B$956.40M26.81%-$136.16M
Revolution Medicines, Inc.(RVMD)5,981,2125,981,2120$192.77M$232.13M6.51%+$39.36M
Kymera Therapeutics, Inc.(KYMR)5,161,8015,161,8010$207.50M$154.08M4.32%-$53.42M
Ionis Pharmaceuticals, Inc.(IONS)2,428,6133,186,376+757,763$105.28M$151.86M4.26%+$46.58M
Mirum Pharmaceuticals, Inc.(MIRM)4,370,0244,370,0240$109.78M$149.41M4.19%+$39.64M
GH Research PLC(GHRS)10,400,15810,400,1580$110.87M$121.27M3.40%+$10.40M
Protagonist Therapeutics Inc3,755,9903,319,290-436,700$108.66M$115.01M3.22%+$6.35M
Cullinan Therapeutics, Inc.(CGEM)3,196,7015,750,683+2,553,982$54.47M$100.29M2.81%+$45.82M
Olema Pharmaceuticals, Inc.(OLMA)9,135,8939,135,8930$103.42M$98.85M2.77%-$4.57M
Structure Therapeutics IncADS812,9882,487,762+1,674,774$34.84M$97.69M2.74%+$62.85M
Xoma Corp Del3,633,7433,633,7430$87.39M$86.08M2.41%-$1.31M
Kura Oncology, Inc.(KURA)4,786,2934,082,037-704,256$102.09M$84.05M2.36%-$18.04M
4d Molecular Therapeutics In3,922,4133,922,4130$124.97M$82.33M2.31%-$42.64M
Axsome Therapeutics, Inc.(AXSM)0955,000+955,000$0$76.88M2.15%+$76.88M
CG Oncology, Inc.(CGON)1,884,1912,417,885+533,694$82.72M$76.33M2.14%-$6.38M
Merus N V1,172,2491,279,049+106,800$52.79M$75.68M2.12%+$22.89M
AC Immune SASHS(ACIU)14,571,23618,834,936+4,263,700$43.13M$75.15M2.11%+$32.02M
Tyra Biosciences, Inc.(TYRA)4,661,1944,661,1940$76.44M$74.53M2.09%-$1.91M
89bio Inc4,047,3547,568,479+3,521,125$47.11M$60.62M1.70%+$13.51M
Celcuity Inc.(CELC)03,466,000+3,466,000$0$56.77M1.59%+$56.77M
Third Harmonic Bio Inc4,365,9334,365,9330$41.21M$56.76M1.59%+$15.54M
Agios Pharmaceuticals, Inc.(AGIO)01,190,107+1,190,107$0$51.32M1.44%+$51.32M
Zymeworks Inc.(ZYME)5,870,0005,870,0000$61.75M$49.95M1.40%-$11.80M
Essa Pharma Inc8,748,6298,748,6290$74.28M$46.02M1.29%-$28.26M
IDEAYA Biosciences, Inc.(IDYA)1,162,3061,162,3060$51.00M$40.81M1.14%-$10.19M
Lakefront Biotherapeutics NVADR(LKFT)1,863,8091,569,422-294,387$60.01M$38.89M1.09%-$21.12M
Annexon, Inc.(ANNX)7,000,0007,000,0000$50.19M$34.30M0.96%-$15.89M
Repare Therapeutics Inc10,333,60010,333,6000$48.67M$34.10M0.96%-$14.57M
Foghorn Therapeutics Inc.(FHTX)05,302,000+5,302,000$0$30.49M0.85%+$30.49M
Calliditas Therapeutics AbADS750,000750,0000$16.24M$29.24M0.82%+$13.01M
Newamsterdam Pharma Company
ORDINARY SHARES
1,521,9481,521,9480$35.99M$29.24M0.82%-$6.76M
Roivant Sciences Ltd.SHS(ROIV)2,742,4092,742,4090$28.90M$28.99M0.81%+$82.3K
Engene Holdings Inc
COM
2,251,0372,251,0370$38.16M$21.23M0.59%-$16.93M
Janux Therapeutics, Inc.(JANX)2,919,818441,528-2,478,290$109.93M$18.50M0.52%-$91.44M
TScan Therapeutics, Inc.(TCRX)2,989,4742,989,4740$23.74M$17.49M0.49%-$6.25M
Eledon Pharmaceuticals, Inc.(ELDN)4,326,7106,293,282+1,966,572$8.91M$16.61M0.47%+$7.70M
Allakos Inc16,552,41716,552,4170$20.86M$16.55M0.46%-$4.30M
Immunic, Inc.(IMUX)8,902,9728,902,9720$11.75M$9.88M0.28%-$1.87M
Ikena Oncology Inc4,769,1644,769,1640$6.77M$7.87M0.22%+$1.10M
Vigil Neuroscience Inc1,813,6331,813,6330$6.18M$7.25M0.20%+$1.07M
Vistagen Therapeutics, Inc.(VTGN)2,000,0002,000,0000$10.56M$6.96M0.20%-$3.60M
CytomX Therapeutics, Inc.(CTMX)6,595,8015,228,461-1,367,340$14.38M$6.38M0.18%-$8.00M
Elevation Oncology Inc2,312,2002,312,2000$11.86M$6.24M0.17%-$5.62M
Verastem, Inc.(VSTM)1,685,2191,685,2190$19.89M$5.02M0.14%-$14.86M
Cidara Therapeutics Inc0343,055+343,055$0$4.10M0.11%+$4.10M
Verve Therapeutics Inc650,000650,0000$8.63M$3.17M0.09%-$5.46M
Molecular Partners AGADS(MOLN)443,221443,2210$1.72M$3.17M0.09%+$1.45M
Ovid Therapeutics Inc.(OVID)3,853,8183,853,8180$11.75M$2.96M0.08%-$8.79M
SAB Biotherapeutics, Inc.(SABS)917,826917,8260$4.17M$2.85M0.08%-$1.32M
Glycomimetics Inc9,544,2629,544,2620$28.63M$2.69M0.08%-$25.95M
Pieris Pharmaceuticals Inc0257,626+257,626$0$2.55M0.07%+$2.55M
Inventiva S.A.ADS(IVA)686,040686,0400$2.48M$2.02M0.06%-$459.6K
Viracta Therapeutics Inc3,614,6623,614,6620$3.69M$1.97M0.06%-$1.72M
Forte Biosciences Inc2,982,1052,982,1050$2.09M$1.60M0.04%-$488.2K
Engene Holdings IncW EXP 10 31 202
*W EXP 10/31/202
945,402945,4020$4.92M$1.31M0.04%-$3.60M
Nls Pharmaceutics LtdSHS5,747,1265,747,1260$1.04M$1.25M0.03%+$201.7K
Unicycive Therapeutics Inc3,611,6012,200,000-1,411,601$4.98M$1.10M0.03%-$3.88M
Rezolute, Inc.(RZLT)190,815190,8150$486.6K$820.5K0.02%+$333.9K
Molecular Templates Inc522,238522,2380$1.17M$600.6K0.02%-$569.2K
Aslan Pharmaceuticals LtdADS1,049,9991,049,9990$646.0K$315.0K0.01%-$331.0K
An2 Therapeutics Inc1,239,4700-1,239,470$4.03M$0—-$4.03M
Cidara Therapeutics Inc6,861,1270-6,861,127$6.31M$0—-$6.31M
Corvus Pharmaceuticals, Inc.(CRVS)361,4060-361,406$643.3K$0—-$643.3K
Delcath Systems, Inc.(DCTH)1,202,0670-1,202,067$5.73M$0—-$5.73M
Kronos Bio Inc2,905,0430-2,905,043$3.78M$0—-$3.78M
Lexicon Pharmaceuticals, Inc.(LXRX)1,686,9240-1,686,924$4.05M$0—-$4.05M
Pieris Pharmaceuticals Inc20,609,8630-20,609,863$3.78M$0—-$3.78M
Syndax Pharmaceuticals, Inc.(SNDX)1,875,0000-1,875,000$44.63M$0—-$44.63M
Page 1 of 1